Benralizumab Maintains Remission in Asthma in Some, Not All ...Middle East

Achieving and maintaining clinical remission for up to 2 years is feasible for nearly one third of patients with severe eosinophilic asthma receiving benralizumab. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Benralizumab Maintains Remission in Asthma in Some, Not All )

Also on site :

• Maluma Honors Pachuco Culture in Zoot Suit at Met Gala 2025
• Zendaya Suits Up for Her Most Unexpected Look to Date at 2025 Met Gala
• Donna Kelce's 'Sweet' Show of Support for Taylor Swift Ahead of Met Gala